LIFE - アティ―ル・ファ―マ （aTyr Pharma Inc.）LIFEのニュース
The last Hawaiian princess, with a trust valued at $215 million, has died at the age of 96 2022/12/12 19:54:15 Kwhen Finance
aTyr Pharma, Inc. (LIFE) Q3 2022 Earnings Call Transcript 2022/11/11 01:32:07 Seeking Alpha
aTyr Pharma, Inc. (NASDAQ:NASDAQ:LIFE) Q3 2022 Earnings Conference Call November 10, 2022 05:00 PM ET Company Participants Ashlee Dunston - Director, IR & Corporate Communications…
aTyr Pharma GAAP EPS of -$0.46 in-line 2022/11/10 21:02:14 Seeking Alpha
aTyr Pharma press release (LIFE): Q3 GAAP EPS of -$0.46 in-line.Cash, restricted cash, cash equivalents and investments as of September 30, 2022, were $79.6 million
aTyr Pharma Announces Third Quarter 2022 Results and Provides Corporate Update 2022/11/10 21:00:00 Investors Atyrpharma
First patient dosed in Phase 3 EFZO-FIT™ study in patients with pulmonary sarcoidosis; multiple centers in the U.S. are open for enrollment. Company to prioritize resources towards largest value driver efzofitimod program. Ended the third quarter 2022 with $79.6 million in cash, restricted cash,
aTyr Pharma up 5% after hours following Orphan Drug Status for efzofitimod 2022/04/12 22:23:50 Seeking Alpha
The U.S. FDA has granted Orphan Drug Status to aTyr Pharma''s (LIFE) efzofitimod for systemic sclerosis.
aTyr Pharma files for $200M mixed shelf offering 2022/03/15 21:56:48 Seeking Alpha
aTyr Pharma (LIFE) has filed for a $200M mixed shelf offering.The filing does not necessarily indicate that a sale has begun, or will occur in the future.The company said it will use…
aTyr Pharma, Inc. (LIFE) CEO Sanjay Shukla on Q4 2021 Results - Earnings Call Transcript 2022/03/15 03:02:02 Seeking Alpha
Avetta Launches Supply Chain Sustainability and ESG Risk Mitigation Solution on Avetta One Platform 2022/03/13 22:31:00 Kwhen Finance
aTyr Pharma up 5% after hours following Orphan Drug Status for efzofitimod 2022/04/12 22:23:50 Seeking Alpha
The U.S. FDA has granted Orphan Drug Status to aTyr Pharma''s (LIFE) efzofitimod for systemic sclerosis.
aTyr Pharma files for $200M mixed shelf offering 2022/03/15 21:56:48 Seeking Alpha
aTyr Pharma (LIFE) has filed for a $200M mixed shelf offering.The filing does not necessarily indicate that a sale has begun, or will occur in the future.The company said it will use…